Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
- PMID: 26295306
- PMCID: PMC4694895
- DOI: 10.18632/oncotarget.4613
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
Abstract
Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is thought that GBM stem cells (GSCs) are critically important in resistance to therapy. Therefore, there is a strong rationale to target these cells in order to develop new molecular therapies.To identify molecular targets in GSCs, we compared gene expression in GSCs to that in neural stem cells (NSCs) from the adult human brain, using microarrays. Bioinformatic filtering identified 20 genes (PBK/TOPK, CENPA, KIF15, DEPDC1, CDC6, DLG7/DLGAP5/HURP, KIF18A, EZH2, HMMR/RHAMM/CD168, NOL4, MPP6, MDM1, RAPGEF4, RHBDD1, FNDC3B, FILIP1L, MCC, ATXN7L4/ATXN7L1, P2RY5/LPAR6 and FAM118A) that were consistently expressed in GSC cultures and consistently not expressed in NSC cultures. The expression of these genes was confirmed in clinical samples (TCGA and REMBRANDT). The first nine genes were highly co-expressed in all GBM subtypes and were part of the same protein-protein interaction network. Furthermore, their combined up-regulation correlated negatively with patient survival in the mesenchymal GBM subtype. Using targeted proteomics and the COGNOSCENTE database we linked these genes to GBM signalling pathways.Nine genes: PBK, CENPA, KIF15, DEPDC1, CDC6, DLG7, KIF18A, EZH2 and HMMR should be further explored as targets for treatment of GBM.
Keywords: GBM; GSCs; glioblastoma; glioblastoma stem cells; therapeutic targeting.
Conflict of interest statement
None.
Figures








Similar articles
-
A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.Cancer Lett. 2016 Feb 28;371(2):240-50. doi: 10.1016/j.canlet.2015.11.040. Epub 2015 Dec 9. Cancer Lett. 2016. PMID: 26683773
-
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.Oncotarget. 2015 Nov 10;6(35):37241-56. doi: 10.18632/oncotarget.5925. Oncotarget. 2015. PMID: 26437223 Free PMC article.
-
A Multistep In Silico Approach Identifies Potential Glioblastoma Drug Candidates via Inclusive Molecular Targeting of Glioblastoma Stem Cells.Mol Neurobiol. 2024 Nov;61(11):9253-9271. doi: 10.1007/s12035-024-04139-y. Epub 2024 Apr 15. Mol Neurobiol. 2024. PMID: 38619743
-
The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.Int J Mol Sci. 2021 Apr 8;22(8):3863. doi: 10.3390/ijms22083863. Int J Mol Sci. 2021. PMID: 33917954 Free PMC article. Review.
-
Collateral damage control in cancer therapy: defining the stem identity in gliomas.Curr Pharm Des. 2011;17(23):2370-85. doi: 10.2174/138161211797249198. Curr Pharm Des. 2011. PMID: 21827417 Review.
Cited by
-
Impaired Expression of Cytoplasmic Actins Leads to Chromosomal Instability of MDA-MB-231 Basal-Like Mammary Gland Cancer Cell Line.Molecules. 2021 Apr 8;26(8):2151. doi: 10.3390/molecules26082151. Molecules. 2021. PMID: 33917969 Free PMC article.
-
Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells.Sci Adv. 2022 Mar 4;8(9):eabl5621. doi: 10.1126/sciadv.abl5621. Epub 2022 Mar 2. Sci Adv. 2022. PMID: 35235361 Free PMC article.
-
Centromeric and ectopic assembly of CENP-A chromatin in health and cancer: old marks and new tracks.Nucleic Acids Res. 2019 Feb 20;47(3):1051-1069. doi: 10.1093/nar/gky1298. Nucleic Acids Res. 2019. PMID: 30590707 Free PMC article. Review.
-
NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis.Cancer Sci. 2017 Jan;108(1):12-22. doi: 10.1111/cas.13117. Cancer Sci. 2017. PMID: 27862769 Free PMC article.
-
Targeting different domains of gap junction protein to control malignant glioma.Neuro Oncol. 2018 Jun 18;20(7):885-896. doi: 10.1093/neuonc/nox207. Neuro Oncol. 2018. PMID: 29106645 Free PMC article. Review.
References
-
- Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, Scheie D, Vik A, Meling TR. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta neurologica Scandinavica. 2010;122:159–167. - PubMed
-
- Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–466. Epub 2009 Mar 2009. - PubMed
-
- Moe MC, Varghese M, Danilov AI, Westerlund U, Ramm-Pettersen J, Brundin L, Svensson M, Berg-Johnsen J, Langmoen IA. Multipotent progenitor cells from the adult human brain: neurophysiological differentiation to mature neurons. Brain. 2005;128:2189–2199. - PubMed
-
- Moe MC, Westerlund U, Varghese M, Berg-Johnsen J, Svensson M, Langmoen IA. Development of neuronal networks from single stem cells harvested from the adult human brain. Neurosurgery. 2005;56:1182–1188. discussion 1188–1190. - PubMed
-
- Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nature medicine. 1998;4:1313–1317. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous